SCHEMBL21168537

SCHEMBL21168537

c1ccc(-c2cc(-c3ccccc3)nc(-c3cccc(-c4cccc5c4-c4ccccc4C54c5ccccc5-c5c(-c6cccc(-c7nc(-c8ccccc8)cc(-c8ccccc8)n7)c6)cccc54)c3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.46
KMT2A Q03164 8/20 0.46
MAPT P10636 7/20 0.46
ALDH1A1 P00352 4/20 0.46
HPGD P15428 4/20 0.46
LMNA P02545 3/20 0.46
KDM4E B2RXH2 2/20 0.46
ADORA1 P30542 3/20 0.42
ADORA2A P29274 2/20 0.42
NTSR1 P30989 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
TDP1 Q9NUW8 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
GLA P06280 1/20 0.40
MAPK10 P53779 1/20 0.40
AGTR1 P30556 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17031672 0.99 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19885870 0.97 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19885920 0.97 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL21168612 0.96 MEN1 (0.46) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL24293449 0.95 MEN1 (0.42) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19383464 0.95 MEN1 (0.46) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19383095 0.94 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22646648 0.93 MEN1 (0.41) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL15593085 0.93 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19885862 0.93 MEN1 (0.43) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230126748-A1 POLYMER, A COMPOSITION, AND AN ELECTROLUMINESCENT DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-04-27 US disclosed
US-20230126748-A1 POLYMER, A COMPOSITION, AND AN ELECTROLUMINESCENT DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-04-27 US disclosed
US-11233200-B2 Condensed cyclic compound, composition including the same, and organic light-emitting device including the condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-01-25 US disclosed
US-20200212306-A1 QUANTUM DOT ELECTROLUMINESCENCE DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-07-02 US disclosed
US-20190221746-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11233200-B2 Condensed cyclic compound, composition including the same, and organic light-emitting device including the condensed cyclic compound CRY1, CRY2, MCM4 MEN1 203/4885KMT2A 1648/4885MAPT 1836/4885
US-20190221746-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND CRY1, CRY2, MCM4 MEN1 203/4885KMT2A 1648/4885MAPT 1836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.